Advertisement

Decompression Endoscopic Surgery for Frontal Secondary Headache Attributed to Supraorbital and Supratrochlear Nerve Entrapment: The Utrecht Experience

  • Boris FilipovićEmail author
  • J. Alexander de Ru
  • Peter J. F. M. Lohuis
Chapter

Abstract

In the last decade, a new surgical treatment modality was developed for frontal secondary headache, based on the assumption that the trigger of this pain entity is the entrapment of peripheral sensory nerves. The surgery entails a procedure, where an endoscopic approach is used to decompress the supraorbital and supratrochlear nerve branches, which are entrapped by the periosteum in the region of the corrugator supercilii muscle. Candidates for the surgery define their headache as moderate to severe persistent daily pressure or tension, localized in the frontal area, sometimes accompanied by symptoms of nausea and photophobia mimicking a primary headache—migraine. We created a step-by-step screening algorithm which is used to differentiate patients that have the highest chance for a successful surgical decompression. Up to now, published data regarding this type of surgery demonstrate long-lasting successful outcomes, while adverse effects are minor.

Keywords

Secondary headache Migraine Nerve entrapment Decompression endoscopic surgery Migraine surgery Botulinum toxin type A 

References

  1. 1.
    World Health Organization. Headache disorders. 2012. http://www.who.int/mediacentre/factsheets/fs277/en/. Accessed 11 Sept 2016.
  2. 2.
    Guyuron B, Varghai A, Michelow BJ, Thomas T, Davis J. Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg. 2000;106:429–34.CrossRefGoogle Scholar
  3. 3.
    Janis JE, Ghavami A, Lemmon JA, Leedy JE, Guyuron B. Anatomy of the corrugator supercilii muscle: part I. corrugator topography. Plast Reconstr Surg. 2007;120:1647–53.CrossRefGoogle Scholar
  4. 4.
    Janis JE, Ghavami A, Lemmon JA, Leedy JE, Guyuron B. The anatomy of the corrugator supercilii muscle: part II. Supraorbital nerve branching patterns. Plast Reconstr Surg. 2008;121:233–40.CrossRefGoogle Scholar
  5. 5.
    Janis JE, Hatef DA, Hagan R, Schaub T, Liu JH, Thakar H, Bolden KM, Heller JB, Kurkjian TJ. Anatomy of the supratrochlear nerve: implications for the surgical treatment of migraine headaches. Plast Reconstr Surg. 2013;131:743–50.CrossRefGoogle Scholar
  6. 6.
    Dirnberger F, Becker K. Surgical treatment of migraine headaches by corrugator muscle resection. Plast Reconstr Surg. 2004;114:652–7.CrossRefGoogle Scholar
  7. 7.
    Bearden WH, Anderson RL. Corrugator superciliaris muscle excision for tension and migraine headaches. Ophthal Plast Reconstr Surg. 2005;21:418–22.CrossRefGoogle Scholar
  8. 8.
    de Ru JA, Schellekens PP, Lohuis PJ. Corrugator supercilii transection for headache emanating from the frontal region: a clinical evaluation of ten patients. J Neural Transm. 2011;118:1571–4.CrossRefGoogle Scholar
  9. 9.
    Gfrerer L, Maman DY, Tessler O, Austen WG Jr. Nonendoscopic deactivation of nerve triggers in migraine headache patients: surgical technique and outcomes. Plast Reconstr Surg. 2014;134:771–8.CrossRefGoogle Scholar
  10. 10.
    Edoardo R, Giorgia C. Frontal endoscopic myotomies for chronic headache. J Craniofac Surg. 2015;26:201–3.CrossRefGoogle Scholar
  11. 11.
    The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.CrossRefGoogle Scholar
  12. 12.
    Filipović B, de Ru JA, van de Langenberg R, Borggreven PA, Lacković Z, Lohuis PJFM. Decompression endoscopic surgery for frontal secondary headache attributed to supraorbital and supratrochlear nerve entrapment: a comprehensive review. Eur Arch Otorhinolaryngol. 2017;274:2093–106.  https://doi.org/10.1007/s00405-017-4450-x.CrossRefPubMedGoogle Scholar
  13. 13.
    Lee M, Monson MA, Liu MT, Reed D, Guyuron B. Positive botulinum toxin type a response is a prognosticator for migraine surgery success. Plast Reconstr Surg. 2013;131:751–7.CrossRefGoogle Scholar
  14. 14.
    Kung TA, Guyuron B, Cederna PS. Migraine surgery: a plastic surgery solution for refractory migraine headache. Plast Reconstr Surg. 2011;127:181–9.CrossRefGoogle Scholar
  15. 15.
    Liu MT, Armijo BS, Guyuron B. A comparison of outcome of surgical treatment of migraine headaches using a constellation of symptoms versus botulinum toxin type a to identify the trigger sites. Plast Reconstr Surg. 2012;129:413–9.CrossRefGoogle Scholar
  16. 16.
    de Ru JA, Buwalda J. Botulinum toxin a injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache. J Laryngol Otol. 2008;123:412–7.PubMedGoogle Scholar
  17. 17.
    Fozzard HA, Lee PJ, Lipkind GM. Mechanism of local anesthetic drug action on voltage-gated sodium channels. Curr Pharm Des. 2005;11:2671–86.CrossRefGoogle Scholar
  18. 18.
    Blasi J, Chapman ER, Link E, et al. Botulinum neurotoxin a selectively cleaves the synaptic protein SNAP-25. Nature. 1993;365:160–3.CrossRefGoogle Scholar
  19. 19.
    Silberstein SD. The use of Botulinum toxin in the Management of Headache Disorders. Semin Neurol. 2016;36:92–8.CrossRefGoogle Scholar
  20. 20.
    Fallucco M, Janis JE, Hagan RR. The anatomical morphology of the supraorbital notch: clinical relevance to the surgical treatment of migraine headaches. Plast Reconstr Surg. 2012;130:1227–33.CrossRefGoogle Scholar
  21. 21.
    Liu MT, Chim H, Guyuron B. Outcome comparison of endoscopic and transpalpebral decompression for treatment of frontal migraine headaches. Plast Reconstr Surg. 2012;129:1113–9.CrossRefGoogle Scholar
  22. 22.
    Janis JE, Barker JC, Javadi C, Ducic I, Hagan R, Guyuron B. A review of current evidence in the surgical treatment of migraine headaches. Plast Reconstr Surg. 2014;134:131–41.CrossRefGoogle Scholar
  23. 23.
    Chepla KJ, Oh E, Guyuron B. Clinical outcomes following supraorbital foraminotomy for treatment of frontal migraine headache. Plast Reconstr Surg. 2012;129:656–62.CrossRefGoogle Scholar
  24. 24.
    Kurlander DE, Punjabi A, Liu MT, Sattar A, Guyuron B. In-depth review of symptoms, triggers, and treatment of temporal migraine headaches (site II). Plast Reconstr Surg. 2014;133:897–903.CrossRefGoogle Scholar
  25. 25.
    Janis JE, Hatef DA, Reece EM, McCluskey PD, Schaub TA, Guyuron B. Neurovascular compression of the greater occipital nerve: implications for migraine headaches. Plast Reconstr Surg. 2010;126:1996–2001.CrossRefGoogle Scholar
  26. 26.
    Larson K, Lee M, Davis J, Guyuron B. Factors contributing to migraine headache surgery failure and success. Plast Reconstr Surg. 2011;128:1069–75.CrossRefGoogle Scholar
  27. 27.
    Yancey JR, Sheridan R, Koren KG. Chronic daily headache: diagnosis and management. Am Fam Physician. 2014;89:642–8.PubMedGoogle Scholar
  28. 28.
    Olesen J, Peer Tfelt-Hansen K, Welch A, Goadsby PJ, Ramadan NM. The headaches third edition. Philadelphia: Lippincott Williams and Wilkins; 2006.Google Scholar
  29. 29.
    Villalón CM, Centurión D, Valdivia LF, de Vries P, Saxena PR. Migraine: pathophysiology, pharmacology, treatment and future trends. Curr Vasc Pharmacol. 2003;1:71–4.CrossRefGoogle Scholar
  30. 30.
    Filipovic B, de Ru JA, Hakim S, van de Langenberg R, Borggreven PA, Lohuis PJFM. Treatment of frontal secondary headache attributed to Supratrochlear and supraorbital nerve entrapment with Oral medication or Botulinum toxin type a vs endoscopic decompression surgery. JAMA Facial Plast Surg. 2018 Sep 1;20(5):394–400.  https://doi.org/10.1001/jamafacial.2018.0268.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Omranifard M, Abdali H, Ardakani MR, Talebianfar M. a comparison of outcome of medical and surgical treatment of migraine headache: in 1 year follow-up. Adv Biomed Res. 2016;29(5):121.Google Scholar
  32. 32.
    Diener HC, Dodick DW, Aurora SK, al E. PREEMPT 2 chronic migraine study group. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30:804–14.CrossRefGoogle Scholar
  33. 33.
    Jackson JL, Kuriyama A, Hayashino Y. Botulinum toxin a for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. JAMA. 2012;307:1736–45.CrossRefGoogle Scholar
  34. 34.
    Gady J, Ferneini EM. Botulinum toxin a and headache treatment. Conn Med. 2013;77:165–6.PubMedGoogle Scholar
  35. 35.
    Morra ME, Elgebaly A, Elmaraezy A, et al. therapeutic efficacy and safety of Botulinum toxin a therapy in trigeminal neuralgia: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain. 2016;17:63.CrossRefGoogle Scholar
  36. 36.
    Matak, I, Lacković Z. Botulinum toxin A, brain and pain. Prog Neurobiol. 2014;119–120:39–59.CrossRefGoogle Scholar
  37. 37.
    Lacković Z, Filipović B, Matak I, Helyes Z. Activity of botulinum toxin type a in cranial dura: implications for treatment of migraine and other headaches. Br J Pharmacol. 2016;173:279–91.CrossRefGoogle Scholar
  38. 38.
    Filipović B, Matak I, Lacković Z. Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region. J Neural Transm. 2014;121:555–63.CrossRefGoogle Scholar
  39. 39.
    Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J Clin Epidemiol. 2000;53:786–92.CrossRefGoogle Scholar
  40. 40.
    Freeman TB, Vawter DE, Leaverton PE, al E. use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson’s disease. N Engl J Med. 1999;341:988–92.CrossRefGoogle Scholar
  41. 41.
    Bloudek LM, Stokes M, Buse DC, et al. Cost of healthcare for patients with migraine in five European countries: results from the international burden of migraine study (IBMS). J Headache Pain. 2012;13:361–78.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Boris Filipović
    • 1
    • 2
    • 3
    • 4
    Email author
  • J. Alexander de Ru
    • 5
  • Peter J. F. M. Lohuis
    • 2
    • 4
  1. 1.Department of Otorhinolaryngology/Head and Neck SurgeryUniversity Hospital Sveti DuhZagrebCroatia
  2. 2.Department of Otorhinolaryngology/Head and Neck SurgeryCenter for Facial Plastic and Reconstructive Surgery, Diakonessen HospitalUtrechtThe Netherlands
  3. 3.Department of Pharmacology, Laboratory of Molecular NeuropharmacologyUniversity of Zagreb School of MedicineZagrebCroatia
  4. 4.Poliklinika Lohuis Filipović Medical Group d.o.o., Private ClinicZagrebCroatia
  5. 5.Department of Otorhinolaryngology/Head and Neck SurgeryCentral Military HospitalUtrechtThe Netherlands

Personalised recommendations